Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

(MedPage Today) — PHOENIX — Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, and major cardiovascular events compared with semaglutide (Ozempic, Wegovy) in high-risk patients with…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118194

Author :

Publish date : 2025-10-28 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Quantum-inspired algorithm could help reveal hidden cosmic objects

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Related Posts

Major Developments in Psoriatic Disease

ADHD App Cleared; Anti-Inflammatories for Depression; Charges Over Adderall Scripts

Big Bump in Concierge, Direct Primary Care in Recent Years

Undesired Weight Gain Common in HIV Patients on ART

Improving Oral Chemotherapy Adherence in Pediatric ALL

Virtual Weight-Loss Program Shows Potential for Vets With Serious Mental Illness

Major Developments in Psoriatic Disease

ADHD App Cleared; Anti-Inflammatories for Depression; Charges Over Adderall Scripts

Big Bump in Concierge, Direct Primary Care in Recent Years

Undesired Weight Gain Common in HIV Patients on ART

Improving Oral Chemotherapy Adherence in Pediatric ALL

Virtual Weight-Loss Program Shows Potential for Vets With Serious Mental Illness

Top Cancer Center to Cough Up $15 Million to Settle Fraud Allegations

Brain Tumor Warning Added to Birth Control Shot

Categories

Archives